Bionano Genomics, Inc. (BNGO) research

Bionano Genomics, Inc.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Last price: $1.48
As of: 2026-10-02

Bionano Genomics, Inc. (BNGO): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-14.

As of 2026-09-14, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for BNGO. Method and limitations.

COMPANY DOSSIER

See the full BNGO dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for BNGO on one page. Preview it with sample data, then open it live with a free account.

Preview the BNGO dossier

Active signals for BNGO

mediumEARNINGS_BEAT2026-09-08
Q2-2026: Beat consensus by 8.4%, EPS $-0.64 vs $-0.6987 estimate
All 2026-09-08 signals →
mediumEARNINGS_BEAT2026-06-25
Q4-2025: Beat consensus by 97.9% - EPS $-0.03 vs $-1.428 estimate
All 2026-06-25 signals →
mediumEARNINGS_BEAT2026-06-25
Q1-2026: Beat consensus by 15.3% - EPS $-0.76 vs $-0.8976 estimate
All 2026-06-25 signals →
mediumEARNINGS_BEAT2026-06-02
Beat consensus by 15.3% - EPS $-0.76 vs $-0.8976 estimate
All 2026-06-02 signals →
mediumEARNINGS_BEAT2026-05-26
Q2-2025: Beat consensus by 19.2% - EPS $-1.99 vs $-2.4633 estimate
All 2026-05-26 signals →

FREE, NO ACCOUNT

Every signal on BNGO, as it fires

You are seeing 5 of 8 signals recorded on BNGO since 2026-05-26.

The five above landed across 4 days. The other 3 were recorded on those same days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in BNGO (2026Q2)

Manager / security	Market value	% portfolio	QoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 09075F404 · 2026Q2	$58K	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, BNGO

8-K2026-09-14
SEC EDGAR ↗
10-Q2026-08-10
SEC EDGAR ↗
8-K2026-08-10
SEC EDGAR ↗
8-K2026-06-24
SEC EDGAR ↗
8-K2026-06-05
SEC EDGAR ↗
8-K2026-05-28
SEC EDGAR ↗
8-K2026-05-14
SEC EDGAR ↗
8-K2026-05-13
SEC EDGAR ↗
10-Q2026-05-13
SEC EDGAR ↗
8-K2026-05-06
SEC EDGAR ↗

BNGO against its peers

BNGO's operating margin of -116.9% ranks in the 26th percentile of 16 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.

Metric	BNGO	Peer median	Percentile	n
Revenue FY	28.5M USD	20.7M USD	53	17
Revenue YoY	n/a	65.2%	n/a	5
Gross margin	n/a	46.1%	n/a	16
Operating margin	-116.9%	-42.3%	26	16
Net margin	-92.6%	-32.8%	31	17
Return on equity	-59.4%	-67.3%	53	19

Peers (21): FEMY, RVP, CUPR, RGNT, HBIO, MLSS, UEEC, NEPH, LUCY, POCI, MHUAF, MBOT, STXS, KRMD, NYXH, ZJYL, PDEX, YBGJ, GCTK, NXGL, UTMD. Left out: ZTEK (no annual filing), DXR (no annual filing), RSCF (period gap), TUTH (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (BNGO: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more BNGO signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to BNGOand get the insider, 13F, options, and confluence read in one view.